David Y Dy- MD, MS, MBE, FACS
- surgical oncologist at St. Luke's Medical Center (Philippines)
David Y Dy
- MD, MS, MBE, FACS
- surgical oncologist at St. Luke's Medical Center (Philippines)
private practice in surgical oncology
About
24
Publications
13,544
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
214
Citations
Introduction
I am an experienced medical doctor with expertise in the diagnosis, treatment and operation of adult cancer patients. I have had the privilege of serving patients at one of the premier healthcare institutions in the Philippines for almost 30 years. My primary objective is to provide state-of-the-art, professional medical care with unwavering dedication to courtesy, efficiency, and utmost respect for patient confidentiality.
Current institution
Additional affiliations
February 1990 - December 1991
Position
- Hon Surgical Registrar & Clinical Research Fellow
Description
- cancer surgery, colon cancer, somatostatin, hormonal control, proliferation assay
August 1992 - June 1993
Position
- Graduate Research Assistant
Description
- cancer, metastasis
February 1990 - December 1991
Education
July 2001 - May 2006
August 1992
Field of study
- Graduate Research Assistant (Cancer Biology)
February 1990 - June 1992
Publications
Publications (24)
Background:
The antitumor activity of lymphokine activated killer (LAK) cells immunotherapy is not always effective in all patients, especially when used alone. In this study, we investigated the in vitro antitumor activities of a combination of LAK immunotherapy and gene therapy employing an adenovirus carrying the p53 gene (Ad-p53) in human head...
Cancer or malignant neoplasm has been plaguing people all over the world. Cancer, as a cause of mortality, ranks fourth in the world in the year 2002; ranks second in the United States of America in the year 2000; and ranks third in the Philippines in the year 2000. In the country, in terms of kind of cancer, malignant neoplasm of trachea, bronchus...
The effect of a long-acting somatostatin analogue SMS 201.995 (SMS; Sandoz) on basal and gastrin-stimulated growth of 4 human colon cancer lines was studied in vitro and in vivo. Proliferation assay was done with overnight [75Se]selenomethionine uptake after 5 days of incubation. Gastrin concentrations used were 5e-10 M and 1e-7 M. SMS concentratio...
Somatostatin receptors of human gastrointestinal cancer specimens and cell lines were measured using in vitro film autoradiography. Four colon and one gastric cancer cell lines when grown as xenografts were receptor-positive. Of the 31 human colorectal cancers, forty percent were receptor-positive, and there was an association between advanced stag...
This study investigated the effect of SMS 201.995 on CEA secretion of human colon cancer cell lines in vitro and as xenografts in nude mice. Using the two cell lines which secreted significant amounts of CEA in the media, there was a 40% and 54% decrease in CEA level at 2e-10M and 2e-9M concentrations of SMS 201.995, respectively, after five days o...
Hepatic cryotherapy is increasingly used in the treatment of patients with multiple hepatic metastases, particularly from colorectal cancer. The Cryotech LCS 2000 system, with insulated shaft-circulated liquid nitrogen probes, was designed for this purpose and was evaluated on the bench and in an animal model. The 9-mm probe was considerably more e...
